Biotechnology and Pharmaceuticals

The HC-BP category groups firms that discover, develop, manufacture and market biotech and pharmaceutical products, including small-molecule drugs, biologics, vaccines and related therapies. Its sustainability focus covers product safety and efficacy, ethical clinical testing, equitable access to medicine, responsible R&D, and the management of manufacturing waste, emissions and energy use.